The Department of Pharmaceuticals, Government of India, organised an Industry dialogue on the Promotion of Research and ...

Focus needs to shift from a push to capital-, tech- and skill-intensive sectors to labour- & low-skill intensive ones.

With the expiry of patents for several essential medicines, the prices of key drugs, including those for diabetes, asthma, ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

It is a positive sign for investors that directors of several well-known listed firms are purchasing their own shares, believing them to be undervalued amid a lack of buyers.

According to media reports, her net worth is estimated at Rs 600 crore, a major chunk of which comes from Emcure. Namita ...

While Trump’s tariffs aren’t designed to help India, they may inadvertently provide the external catalyst needed for India’s ...

Tata Motors leads Nifty 100 companies in R&D spending, focusing on mobility solutions and alternative fuel technologies.

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from ...

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...